T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse

We analyzed 67 patients with lymphoma who received alemtuzumab-based conditioning regimens for allogeneic stem cell transplant and no post-transplant DLI. The median age was 54 (24–70), 43% had unrelated donors, 34% had chemotherapy refractory disease, and 25% had an elevated LDH. With a median foll...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: KENKRE, VAISHALEE P., HOROWITZ, SARAH, ARTZ, ANDREW S., LIAO, CHUANHONG, COHEN, KENNETH S., GODLEY, LUCY A., KLINE, JUSTIN P., SMITH, SONALI M., STOCK, WENDY, VAN BESIEN, KOEN
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3617078/
https://ncbi.nlm.nih.gov/pubmed/21142785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2010.538777
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars